Laura Melado

ORCID: 0000-0001-5450-4130 · 10 papers in corpus
case-report 2026
Case Reports in Obstetrics and Gynecology ·doi:10.1155/crog/4150637

OBJECTIVE: The objective of this study is to evaluate the effectiveness of prolonged GnRH agonist (GnRH-a) suppression combined with letrozole and intensive luteal phase support in a patient with severe adenomyosis undergoing frozen-thawed …

case-report 2026
Journal of medical case reports ·doi:10.1186/s13256-026-05907-1

BACKGROUND: Adenomyosis negatively impacts fertility treatment outcomes by lowering clinical pregnancy rates, reducing live birth rates, and increasing miscarriage rates following in vitro fertilization. Hormonal suppression therapy has eme…

observational 2025
Frontiers in endocrinology ·doi:10.3389/fendo.2025.1654365

INTRODUCTION: Anti-Müllerian Hormone (AMH) and antral follicle count (AFC) are commonly used markers of ovarian reserve, yet their predictive accuracy in patients with low ovarian reserve remains limited. This study aimed to evaluate whethe…

observational 2025
Journal of assisted reproduction and genetics ·doi:10.1007/s10815-025-03637-9

BackgroundInhibin B (InhB) is secreted by granulosa cells and reflects early follicular activity. While anti-Müllerian hormone (AMH) and antral follicle count (AFC) are established ovarian reserve markers, the role of bioavailable inhibin B…

review 2024
Best practice & research. Clinical obstetrics & gynaecology ·doi:10.1016/j.bpobgyn.2024.102456

As a chronic inflammatory disease, endometriosis generates fibrosis and anatomic distortion, which add extra-challenges to assisted reproductive technology cycles and requires a personalized approach. Patients with endometriomas have signif…

guideline 2024
Frontiers in endocrinology ·doi:10.3389/fendo.2024.1506332

BACKGROUND: In a global effort to assess expert perspectives on the use of recombinant gonadotropins, recombinant human luteinizing hormone (r-hLH) and recombinant human follicle-stimulating hormone (r-hFSH), a consensus meeting was held in…

rct 2021
Frontiers in endocrinology ·doi:10.3389/fendo.2021.661707

A rise in serum progesterone in the late follicular phase is a well described adverse effect of ovarian stimulation for IVF/ICSI. Previous data suggest, that enhanced gonadotropin stimulation causes progesterone elevation and the incidence …

review 2020
·doi:10.1201/9781351241694-8

Luteal phase support is becoming a highly personalized treatment based on each stimulation protocol and patient characteristics. After the application of human chorionic gonadotrophin (hCG) for final oocyte maturation, the vaginal route for…

observational 2020
Frontiers in endocrinology ·doi:10.3389/fendo.2020.609524

CONTEXT: The widespread distribution of the Vitamin D (VitD) receptor in reproductive tissues suggests an important role for VitD in human reproduction. The assessment of patient´s VitD is based on the 25-hydroxyvitamin D (25(OH)D) metaboli…

case-report 2007
·doi:10.1016/s0304-5013(07)73236-3

Resumen Presentamos el caso de una paciente con endometriosis infiltrativa profunda, previamente intervenida de endometriosis ovarica, y su manejo posterior. La clinica de la paciente fue el indicador principal de la progresion de la enferm…